TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options
NCT00115050
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
260
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
TMC114
Sponsor
Tibotec Pharmaceuticals, Ireland